Track topics on Twitter Track topics that are important to you
Founded in Geneva in 2003, Endosense is a medical technology company focused on improving efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. The company has pioneered the use of contact force measurement in catheter ablation, with the development of its proprietary Touch+Â® sensor technology. Endosenseâs flagship product is the TactiCath, the first force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure.
The TactiCath contact force ablation catheter, a combination of the Endosense device and the EnSite Precision cardiac mapping -More-
Founded in Geneva in 2003, Endosense is a medical technology company focused on improving efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac ar...
Ysios Capital is an independent venture capital firm providing private equity financing to early through late-stage human healthcare and biotechnology companies with special focus...
We have published hundreds of Endosense news stories on BioPortfolio along with dozens of Endosense Clinical Trials and PubMed Articles about Endosense for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Endosense Companies in our database. You can also find out about relevant Endosense Drugs and Medications on this site too.